Literature DB >> 24330143

Relationship between endothelial dysfunction and kidney disease.

Tomoyuki Kabutoya1, Satoshi Hoshide, Yukiyo Ogata, Kazuo Eguchi, Kazuomi Kario.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24330143      PMCID： PMC8031774          DOI： 10.1111/jch.12236

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  5 in total

1.  The time course of flow-mediated vasodilation and endothelial dysfunction in patients with a cardiovascular risk factor.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Tomohiko Iwata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Am Soc Hypertens       Date:  2012-02-09

2.  Masked hypertension defined by ambulatory blood pressure monitoring is associated with an increased serum glucose level and urinary albumin-creatinine ratio.

Authors:  Joji Ishikawa; Satoshi Hoshide; Kazuo Eguchi; Joseph E Schwartz; Thomas G Pickering; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08       Impact factor: 3.738

3.  Inflammatory markers should be assessed together with cardiovascular risk factors by clinicians in masked hypertension.

Authors:  Sevket Balta; Sait Demirkol; Turgay Celik; Murat Unlu; Ugur Kucuk; Zekeriya Arslan
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-29       Impact factor: 3.738

4.  Masked hypertension as an unrecognized destructive condition.

Authors:  Sevket Balta; Mustafa Demir; Ugur Kucuk; Zekeriya Arslan; Sait Demirkol; Murat Unlu
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-12       Impact factor: 3.738

5.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.